Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
Open Access
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy.2008
- Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.2007
- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in EuropeBritish Journal of Dermatology, 2005
- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studiesJournal of the American Academy of Dermatology, 2004
- Evaluation of Superficial Basal Cell Carcinomas After Treatment With Imiquimod 5% Cream or Vehicle for Apoptosis and Lymphocyte PhenotypingDermatologic Surgery, 2003
- Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 casesAnais Brasileiros de Dermatologia, 2002
- Efficacy of Topical 5% Imiquimod Cream for the Treatment of Nodular Basal Cell CarcinomaArchives of Dermatology, 2002
- Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary reportJournal of Dermatological Treatment, 2002
- Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trialJournal of the American Academy of Dermatology, 2001
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% creamJournal of the American Academy of Dermatology, 1999